南加大医疗决策分析硕士项目宣讲会
时间：12月3日周一中午12:30
地点：复旦大学邯郸校区马锦明楼109室
*该宣讲会需要提前注册http://uscshanghai.mikecrm.com/UKcNZF7 欢迎参加
Master of Science in Healthcare Decision Analysis
Program Overview:
The Master of Science in Healthcare Decision Analysis (HCDA) is a unique, interdisciplinary program designed to prepare graduates seeking to improve their business and analytical abilities to enter careers in the healthcare sector related to product value and pricing, international access and reimbursement, and competitive business intelligence. HCDA follows a strategic approach to learning and focuses on the intersection of health economics, global coverage and health delivery, and applied international health policy. The program provides an opportunity for students to be at the forefront of a field in which current insurers, the pharmaceutical industry, healthcare systems and consulting firms cannot find enough qualified individuals to meet demand.
Program Highlights:
Concentrated 1 weekends per-semester schedule ideal for working professionals
Adult education learning emphasizing case au dies, team projects, war games
Coursework suitable for most business, science, economic and industry professionals
No course prerequisites or pre-set order of classes
Flexible distance and classroom learning including 'on-demand' lectures
Top 10 nationally ranked USC School of Pharmacy, No. 1 ranked private pharmacy school
Areas of Specialization:
Biopharmaceutical Marketing
Business Intelligence
Health Economics
Managed Care
Policy Analysis
Pricing
Value, Access, and Reimbursement
Course Structure:
The HCDA program is structured for easy access to both full-time and part-time students, and to allow each of them to progress at their own pace. The completion of eleven courses totaling 33 units is a requirement for graduation. No thesis is required.
For more information, go to https://hcda.usc.edu/
Speaker Profiles:
Mr. Grant Lawless, RPh, MD
Program Director of M.S. in Healthcare Decision Analysis (HCDA) and M.S. in Biopharmaceutical Marketing (BPMK)
Associate Professor of Pharmaceutical and Health Economics, USC School of Pharmacy
Ms. Michelle Ton
Senior Program Administrator, Academic and Student Affairs
Healthcare Decision Analysis and Biopharmaceutical Marketing
南加大医疗决策分析硕士项目简介
南加州大学药学院的医疗决策分析硕士项目（MS in Healthcare Decision Analysis，简称HCDA）是全美首创的此类项目。
HCDA的课程设置兼具 “紧凑” 和 “跨领域” 两大特点，内容涵盖专业的数据分析、国际化渠道及偿付、产品估价及定价、医保设计及运作。课程极具强有竞争力的商业视野，尤其适合毕业后志在医药医疗领域发展的学生，为日益多元化的医药医疗领域做准备。
HCDA项目适合已经拥有医药学和医学专业学位的学生，和其他拥有应用科学、经济学、商科等学业背景的本科生。
注册：http://uscshanghai.mikecrm.com/UKcNZF7
外事处
2018-11-9